- Home
- BIVI vs IBG Comparison
BIVI vs IBG Comparison
Compare BIVI & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIVI | IBG |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 8.8M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | BIVI | IBG |
|---|---|---|
| Price | $1.22 | $2.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 74.6K | ★ 116.8K |
| Earning Date | 02-10-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,931,243.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.16 | $1.48 |
| 52 Week High | $25.76 | $9.85 |
Technical Indicators
Market Signals| Indicator | BIVI | IBG |
|---|---|---|
| Relative Strength Index (RSI) | 27.36 | 46.94 |
| Support Level | $1.40 | $2.15 |
| Resistance Level | $1.46 | $2.44 |
| Average True Range (ATR) | 0.09 | 0.19 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 9.47 | 26.67 |
Price Performance
Historical ComparisonAbout BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.